Open Access Open Access  Restricted Access Subscription or Fee Access

A Unani Perspective of Zeequn Nafas (Bronchial Asthma): A Brief Communication

Mudasir Maqbool, Irfat Ara


Zeequn Nafas is a widespread interaction of the bronchial system due to a number of influencing factors leading to chronic respiratory impairment. This respiratory impairment or Zeequn Nafas (Bronchial Asthma) has a wide clinical continuum, ranging from readily reversible bronchospasm to severe chronic intractable airflow obstruction. Bronchial asthma is the medical term used to describe Zeequn Nafas. The term Asthma is originated from the Greek word meaning short breathing, panting or labored breathing. Asthma is a complex airway disorder in which several cells and cell components participate. Despite the continuous research around the world, the successful and safe pharmacotherapy of Zeequn Nafas (Bronchial Asthma) continues to challenge the modern medical community. Corticosteroids and other bronchodilators suppress the immune system when used for long periods of time. Taking into account that diseases are the main phenomena of the body, Unani medicine believes in understanding the interaction between the powers of the body to maintain the reactions of the body to the diseases. Results from various research reports that substitute asthma treatments have played a prominent part in relieving symptoms. Interestingly, well-organized clinical studies still are required to illustrate on the effectiveness of treatment regimens. In this short communication, we will briefly review about Unani perspective of Zeequn Nafas (Bronchial Asthma).

Full Text:



Rabban Tabari A. Firdous al-Hekmah (Paradise of Wisdom). Siddiqi MZ, editor. Berlin: The Gibb Memorial Trust; 1928; 321–25.

Al-Rāzī AḤ. Kitāb al-zīna. MS, Muḥammadī Hamdānī Collection; 1957.

Sina I. Al Qanoon Fit Tib. Lucknow: Nami Press; 1906.

Majoosi A. Kamil ul Sanaah (Urdu translation by Kantoori GH). New Delhi: Idara Kitabus Shifa; 2010; 414–27.

Khan MS, Siddiqui M, Aleem S. Effect of Psoralia corylifolia Linn. and Marham-e-Gulabi in Da-al-sadaf (psoriasis). Indian J Tradit Knowl. 2009; 8(3): 425–430.

Ara I, Akbar S, Naime M, Bukhari SB. Response of Herbal Medicine to the Withdrawal of Bronchodilators and Corticosteroids in Bronchial Asthma (Zeequn Nafas) Patients. International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2015; 4(1): 235–42.

Itrat M, Khan TN, Zulkifle M. Unani Medicine and Healthy Living. 2019.

Rasool S, Maqbool M, Joshi Y. Drug utilization studies among ENT patients in various clinical settings: A comprehensive review. J Drug Deliv Ther. 2019; 9(1-s): 481–5.

Maqbool M. Evaluation of Drug Utilization Pattern in The Pediatric Department of A Tertiary Care Hospital in Srinagar, Jammu & Kashmir, India. J Appl Pharm Sci Res. 2019; 2(4): 6–9.

Zehravi M, Maqbool R, Maqbool M, Ara I. To Identify Patterns of Drug Usage among Patients Who Seek Care in Psychiatry Outpatient Department of a Tertiary Care Hospital in Srinagar, Jammu and Kashmir, India. J Pharm Res Int. 2021; 33(31A): 135–140.

Jurjani M. Zakheera-Khwarzam-Shahi. Urdu translation by Khan HH. 1878; 2.

Zehravi M, Maqbool M, Ara I. Healthy Lifestyle and Dietary Approaches to Treating Polycystic Ovary Syndrome: A Review. Open Health. 2022; 3: 60–5.

Arzani K. Selection of the best pollinizer for Siahe Mashhad sweet cherry cultivar. MSc. Thesis. Karaj, Iran: College of Agriculture, University of Tehran.

Ara I, Maqbool M, Bukhari B, Ara N, Hajam TA. Present status, standardization and safety issues with herbal drugs. International Journal of Research in Pharmaceutical Sciences and Technology. 2020; 1(3): 95–101.

Colledge NR. Davidson’s principles and practice of medicine. 2010.

Indhumathi M, Shanuvas A, Velpandian V. Evaluation of Bronchodilator Activity of Siddha Herbo Mineral Drug “Vasanthakusumakara Mathirai” by Exposing Guinea Pig in Histamine Aerosol. Journal of Medical Science and Clinical Research (JMSCR). 2018; 6(6): 371–4.

Barnes PJ. Is immunotherapy for asthma worthwhile? N Engl J Med. 1996 Feb 22; 334(8): 531–2.

Singhal K, Jabin F, Ahmad S, Rahman S, Bhargava R, Latif A. Scientific validation of Unani compound formulation for its efficacy in bronchial asthma. Indian J Tradit Knowl. 2009; 8(3): 421–424.

Ara I, Yaqoob S, Raja WY, Bukhari B, Maqbool M. Managing anxiety disorders: a short communication. World J Pharm Pharm Sci. 2020; 9(3): 1919–1928.

Malik JA, Maqbool M. COVID-19: An overview of current scenario. CELLMED. 2020; 10(3): 21.1–21.8.

Ara I, Yaqoob S, Bukhari B, Ara N, Raja WY, Maqbool M. Aftimoon hindi (cuscuta reflexa roxb.): a miraculous herb. European J Pharm Med Res. 2020 Mar; 7(3): 572–576.

Shamsi Y, Khan R, Nikhat S. Clinically Significant Improvement in a Case of Bronchial Asthma with Unani Medicine: A Case Report. Trad Integr Med. 2019; 4(3): 130–6.

Rai N, Ray A, Jamil SS, Gulati K. Cellular and molecular mechanisms of action of polyherbal preparation UNIM-352 in experimental models of bronchial asthma. Indian J Exp Biol. 2015 Oct; 53(10): 625–31.


  • There are currently no refbacks.

Copyright (c) 2022 Research & Reviews A Journal of Pharmacognosy